Melanoma and Skin Cancer Trials - MASC Trials

19/06/2026

Our team at Melanoma and Skin Cancer Trials would like to congratulate Prof H. Peter Soyer on his appointment as an Officer of the Order of Australia (AO) in this year’s King’s Birthday Honours. This recognition reflects an outstanding career dedicated to excellence, leadership, and advancing research within dermatology and the diagnosis and management of skin cancers.

We are proud to work with Prof Soyer on the IMAGE and ACEMID trials.

Warmest congratulations on this remarkable achievement.

📸Pictured is Prof Soyer alongside Prof Victoria Mar and Prof Mark Shackleton at the MASC Trials 2024 Scientific Meeting.

18/06/2026

🔬 New research coming soon!

Could everyday foods enhance treatment success for people with advanced melanoma?

Join us at the MASC Trials Concept Development Workshop to hear from one of our experts, Dr Ashray Gunjur, who will share valuable insights on how nutrition could complement current melanoma treatments.

📅 Thursday, 25 June 2026 | 9:00 am–1:00 pm AEST
📍 Melbourne + online via Zoom
👉 Register now – https://ow.ly/wnc150ZcA9l
📧 Enquiries: [email protected]

12/06/2026

Have a research idea in melanoma or skin cancer? 🔬

Last chance to submit your new research concepts to be developed through our upcoming MASC Trials Concept Development Workshop.

This is a unique opportunity to present your idea and receive expert, multidisciplinary feedback on study design and methodology in a supportive environment. Whether your concept is early-stage or more developed, we welcome submissions from clinicians, researchers, and allied health professionals.

Your concepts will benefit from input from experts in melanoma and skin cancer, biostatistics, health economics, quality of life, and consumers with lived experience.

💡 Help shape the future of melanoma and skin cancer research.

📅 Thursday, 25 June 2026 | 9:00 am–1:00 pm AEST
📍 Melbourne + online via Zoom
👉 Register now https://ow.ly/zgB850Z6uzg
📧 Submit your concept: [email protected]

10/06/2026

🎉 Recruitment completed 🎉

We are pleased to announce the completion of recruitment for the SOCRATES study!

Congratulations to the teams at Hervey Bay Hospital, Bundaberg Base Hospital, Monash Health and Cabrini Hospital for enrolling the final participants.

This important trial, led by Prof Stephen Nicholls and Dr Sean Tan from the Monash Victorian Heart Institute and supported by Melanoma and Skin Cancer Trials, is investigating the link between immune checkpoint inhibitor (ICI) therapy and heart disease risk in melanoma patients who are starting, have started or completed treatment with immune checkpoint inhibitors. Research has shown that while ICIs are highly effective in treating melanoma, they may also contribute to inflammation and cholesterol build-up (atherosclerosis) in the heart’s blood vessels.

09/06/2026

Vale Professor Richard Scolyer AO
It is with deep sadness that we acknowledge the passing of Professor Richard Scolyer AO, an extraordinary leader whose impact on melanoma research and diagnosis has been felt worldwide. Read more about Richard’s unwavering commitment to our field by visiting the Melanoma Institute Australia tribute -

All of us at Melanoma Institute Australia (MIA) and the wider melanoma community are mourning the loss of our esteemed colleague and friend, Professor Richard Scolyer AO. Richard was a renowned pathologist and a world authority on skin cancer and melanoma diagnoses. His broad knowledge of and passio...

08/06/2026

Have a research idea in melanoma or skin cancer? 🔬

MASC Trials is now calling for new research concepts to be developed through our upcoming Concept Development Workshop.

This is a unique opportunity to present your idea and receive expert, multidisciplinary feedback on study design and methodology in a supportive environment. Whether your concept is early-stage or more developed, we welcome submissions from clinicians, researchers, and allied health professionals.

Your concepts will benefit from input from experts in melanoma and skin cancer, biostatistics, health economics, quality of life, and consumers with lived experience.

💡 Help shape the future of melanoma and skin cancer research.

📅 Thursday, 25 June 2026 | 9:00 am–1:00 pm AEST
📍 Melbourne + online via Zoom
👉 Register now https://ow.ly/zgB850Z6uzg
📧 Submit your concept: [email protected]

31/05/2026

Registrations are now open! Join us for the 2026 MASC Trials Scientific Meeting on Thursday 19 November.

This event will feature Australian leaders in melanoma and skin cancer clinical trials to share the latest discoveries and foster further innovative research.

Anyone interested in melanoma and skin cancers, from healthcare professionals to consumers, should attend the 2026 Scientific Meeting.

Additional speakers are currently being confirmed. Final program and session times will be available soon.

Register below at: https://www.melanoma2026.com/registration

27/05/2026

Shape the future of melanoma and skin cancer research 🔬
Join our Concept Development Workshop and be part of the discussion on emerging research concepts in melanoma and skin cancer. This half-day workshop, facilitated by MASC Trials, offers a supportive, multidisciplinary environment to provide intensive input on study design and methodology.
You will hear from experts in melanoma and skin cancer, biostatistics, health economics, quality of life, and consumers with lived experience.
📅 Thursday, 25 June 2026 | 9am–1pm AEST
📍 553 St Kilda Rd, Melbourne + online via Zoom
👉 Register now – https://ow.ly/50tc50Z4xvE
📧 enquiries: [email protected]

23/05/2026

A thought-provoking congress session by Prof Ashfaq Marghoob on Overdiagnosis of Melanoma & Lentigo Maligna: Shifting Paradigms. The talk highlighted our investigators’ phase 3 randomised clinical trial comparing radiotherapy versus imiquimod for complex lentigo maligna (Hong et al., J Am Acad Dermatol, 2025).